Cancer

Olanzapine appeared to improve symptoms of nausea and vomiting unrelated to chemotherapy or radiotherapy among patients with advanced cancer, according to results of a randomized pilot trial published in JAMA Oncology.

Early intervention is critical in managing patients with immune-related adverse events associated with cancer checkpoint inhibitor therapy, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

Coordinated care between oncology and rheumatology is one of the key principles of the EULAR recommendations for management of immune-related adverse events associated with cancer checkpoint inhibitor therapy, according to data presented at the EULAR 2020 E-Congress.

Viewing a video detailing hospice options did not significantly impact preferences for hospice care among patients with advanced cancer and their caregivers, according to results of a randomized study published in Cancer.

In a systematic review and meta-analysis, a history of cancer was not associated with adverse short- and long-term outcomes in patients who had transcatheter aortic valve replacement.

Medical schools around the country are trying to implement instruction in transgender care into their curriculum. Infectious Diseases in Children asked Katherine L. Margo, MD, emeritus associate professor of family medicine and community health at the University of Pennsylvania Perelman School of Medicine, if transgender health education should be required in medical school curricula.

Patients with certain medical conditions who consume alcohol may be at an increased risk for consuming more than the recommended limit, according to research published in JAMA Network Open.

Patients with cancer enrolled in a supportive oncodermatology program experienced a significant improvement in quality of life, according to a study.

In his excellent editorial in April, Derek Raghavan, MD, PhD, commented that it was unusual for us to cover the same subject in successive editions of HemOnc Today.

Results of a multicenter study presented at the virtual American Association for Cancer Research Annual Meeting showed that individuals with cancer and COVID-19 could be two to three times more likely to die than those with COVID-19 who do not have cancer. This was the top story in hematology/oncology last week.